Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle
- PMID: 11040129
- DOI: 10.1006/viro.2000.0514
Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle
Abstract
The human papillomavirus type 16 encodes two principal oncoproteins, E6 and E7. The E7 protein has been shown to deregulate the cell cycle through interactions with a variety of proteins involved in cell cycle control and transcriptional regulation. These activities result in E7 being able to cooperate with activated oncogenes in the transformation of primary rodent cells, and with the viral E6 protein during human keratinocyte immortalization. Although a large number of activities have been ascribed to the E7 protein, little is known about its regulation during the cell cycle. We have performed a series of studies to investigate potential changes in E7 phosphorylation during the cell cycle and we show that E7 is indeed differentially phosphorylated. Casein kinase II is the principal kinase during the early part of the cell cycle, but this activity decreases rapidly as cells progress toward S phase. In addition, E7 is transiently phosphorylated at Ser71 in S phase by another, as yet unknown, kinase. These results demonstrate differential regulation of the E7 protein during the cell cycle that most likely represents a means of providing specificity to E7's activities.
Copyright 2000 Academic Press.
Similar articles
-
Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor.J Cell Biochem. 2002;85(4):663-9. doi: 10.1002/jcb.10172. J Cell Biochem. 2002. PMID: 11968006
-
The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II.New Biol. 1989 Oct;1(1):44-53. New Biol. 1989. PMID: 2562189
-
HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.Oncogene. 1996 Jun 6;12(11):2325-30. Oncogene. 1996. PMID: 8649772
-
[Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].Rev Invest Clin. 2002 May-Jun;54(3):231-42. Rev Invest Clin. 2002. PMID: 12183893 Review. Spanish.
-
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.Oncogene. 2001 Nov 26;20(54):7888-98. doi: 10.1038/sj.onc.1204860. Oncogene. 2001. PMID: 11753671 Review.
Cited by
-
Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites.Cancers (Basel). 2016 Oct 19;8(10):95. doi: 10.3390/cancers8100095. Cancers (Basel). 2016. PMID: 27775564 Free PMC article. Review.
-
CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells.Viruses. 2022 Jul 30;14(8):1681. doi: 10.3390/v14081681. Viruses. 2022. PMID: 36016303 Free PMC article.
-
Structure-based discovery of novel flavonol inhibitors of human protein kinase CK2.Mol Cell Biochem. 2011 Oct;356(1-2):107-15. doi: 10.1007/s11010-011-0945-8. Epub 2011 Jul 7. Mol Cell Biochem. 2011. PMID: 21735097
-
Focus on HPV Infection and the Molecular Mechanisms of Oral Carcinogenesis.Viruses. 2021 Mar 26;13(4):559. doi: 10.3390/v13040559. Viruses. 2021. PMID: 33810374 Free PMC article. Review.
-
Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.J Virol. 2008 May;82(10):4862-73. doi: 10.1128/JVI.01202-07. Epub 2008 Mar 5. J Virol. 2008. PMID: 18321970 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources